Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
PTN · Nasdaq · United States · Pharmaceutical Preparations
In shortPALATIN TECHNOLOGIES INC is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -65.7% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -63.5% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -877.5% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 4.61× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -1288.77× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -176.87 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -103.0% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 3 | 0/100 |
| Revenue growth volatility | 170.5% | 0/100 |
| Operating margin volatility | 1070.5% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 39.5% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 1.5 | 4.9 | 4.5 | 0 | 13 |
| Cost of revenue | 0.2 | 0.4 | 0.1 | – | – |
| Gross profit | 1.3 | 4.4 | 4.4 | – | – |
| Research & development | 21 | 23 | 22 | 15 | 12 |
| Selling, general & admin | 17 | 15 | 12 | 7.8 | – |
| Operating income | (37) | (32) | (22) | (17) | (8.7) |
| Interest expense | 0 | 0 | 0 | 0 | 0 |
| Pre-tax income | (36) | (32) | – | – | – |
| Income tax | 0 | (4.7) | (30) | (17) | (8.4) |
| Net income | (36) | (24) | (30) | (17) | (8.4) |
| Diluted EPS | – | – | −$101.16 | −$32.15 | −$2.96 |
| Diluted shares (millions) | – | – | 0.3 | 0.5 | 2.8 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of PALATIN TECHNOLOGIES INC are included in the Investor plan. Try free for 7 days →
−176.87 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: . Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice.
Latest annual report: Jun 30, 2026 · Data updated Sep 28, 2026